NYSE:TFX - Teleflex Stock Price, Price Target & More

$271.70 +0.67 (+0.25 %)

(As of 04/23/2018 04:00 PM ET)

Previous Close$271.03

Today's Range$268.38 - $273.54

52-Week Range$191.40 - $288.78

Volume263,199 shs

Average Volume307,809 shs

Market Capitalization$12.21 billion

P/E Ratio32.35

Dividend Yield0.50%

Beta1.17

About Teleflex (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNYSE:TFX

CUSIP87936910

Webwww.teleflex.com

Phone610-225-6800

Debt

Debt-to-Equity Ratio0.89%

Current Ratio2.33%

Quick Ratio1.51%

Price-To-Earnings

Trailing P/E Ratio32.35

Forward P/E Ratio28.13

P/E Growth2

Sales & Book Value

Annual Sales$2.15 billion

Price / Sales5.70

Cash Flow$12.2387 per share

Price / Cash22.20

Book Value$53.95 per share

Price / Book5.04

Profitability

EPS (Most Recent Fiscal Year)$8.40

Net Income$152.53 million

Net Margins7.11%

Return on Equity16.46%

Return on Assets6.97%

Miscellaneous

Employees14,400

Outstanding Shares45,050,000

How to Become a New Pot Stock Millionaire

Teleflex (NYSE:TFX) Frequently Asked Questions

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, February 22nd. Stockholders of record on Friday, March 2nd will be given a dividend of $0.34 per share on Thursday, March 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date is Thursday, March 1st. View Teleflex's Dividend History.

How were Teleflex's earnings last quarter?

Teleflex (NYSE:TFX) issued its quarterly earnings data on Thursday, February, 22nd. The medical technology company reported $2.44 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.40 by $0.04. The medical technology company had revenue of $595.10 million for the quarter, compared to analyst estimates of $601.17 million. Teleflex had a net margin of 7.11% and a return on equity of 16.46%. The business's quarterly revenue was up 15.8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.13 EPS. View Teleflex's Earnings History.

When is Teleflex's next earnings date?

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Teleflex.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY18 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of $9.55-9.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.64.

What price target have analysts set for TFX?

10 Wall Street analysts have issued 1 year price objectives for Teleflex's shares. Their forecasts range from $251.00 to $300.00. On average, they anticipate Teleflex's share price to reach $280.6667 in the next twelve months. View Analyst Ratings for Teleflex.

What are Wall Street analysts saying about Teleflex stock?

Here are some recent quotes from research analysts about Teleflex stock:

1. According to Zacks Investment Research, "Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex was founded in 1943 and is headquartered in Wayne, Pennsylvania. " (10/4/2017)
2. Barclays analysts commented, "XLRS Progressing Slowly with Some Uncertainty. Although top-line safety data from 12 patients in the Phase I/II XLRS dose escalation study did not reveal SAEs and moderate ocular inflammation was considered manageable, the combination of inter-patient and test variability has affected the ability to determine a therapeutic effect. As a result, AGTC plans to expand enrollment and follow the new patients for at least six months." (9/12/2017)
3. Needham & Company LLC analysts commented, "TFX announced it is acquiring NeoTract for $725M of cash upfront and up to another $375M of revenue-based milestone payments. NeoTract has an innovative treatment for benign prostatic hyperplasia (BPH) called UroLift which offers a number of advantages to competing BPH procedures. The BPH market is large and underpenetrated with potential to reach $30B+ worldwide. TFX expects the deal to be accretive to its revenue growth, margins, and EPS by 2019." (9/5/2017)

Who are some of Teleflex's key competitors?

Some companies that are related to Teleflex include Fresenius (FSNUY), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), Abiomed (ABMD), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Cantel Medical (CMD), Penumbra (PEN), Haemonetics (HAE), NuVasive (NUVA) and Nevro (NVRO).

Who are Teleflex's key executives?

Teleflex's management team includes the folowing people:

Mr. Benson F. Smith, Chairman (Age 70)
Mr. Liam J. Kelly, Pres & CEO (Age 51)
Mr. Thomas E. Powell, Exec. VP & CFO (Age 56)
Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 51)
Mr. Cameron P. Hicks, VP of Global HR (Age 53)

Has Teleflex been receiving favorable news coverage?

Headlines about TFX stock have trended somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Teleflex earned a daily sentiment score of 0.12 on Accern's scale. They also gave news stories about the medical technology company an impact score of 45.99 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $271.70.

How big of a company is Teleflex?

Teleflex has a market capitalization of $12.21 billion and generates $2.15 billion in revenue each year. The medical technology company earns $152.53 million in net income (profit) each year or $8.40 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

MarketBeat Community Rating for Teleflex (TFX)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		263 (Vote Outperform)
Underperform Votes:		274 (Vote Underperform)
Total Votes:		537

MarketBeat's community ratings are surveys of what our community members think about Teleflex and other stocks. Vote "Outperform" if you believe TFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TFX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Teleflex (NYSE:TFX) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

10 Wall Street analysts have issued ratings and price targets for Teleflex in the last 12 months. Their average twelve-month price target is $280.6667, suggesting that the stock has a possible upside of 3.30%. The high price target for TFX is $300.00 and the low price target for TFX is $251.00. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.60	2.67	2.67	2.88
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$280.6667	$283.6250	$279.3750	$260.1429
Price Target Upside:	3.30% upside	15.29% upside	2.59% upside	7.60% upside

Teleflex (NYSE:TFX) Consensus Price Target History

Price Target History for Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/4/2018	Goldman Sachs	Initiated Coverage	Neutral -> Neutral	$257.00	Low
2/23/2018	Leerink Swann	Lower Price Target	Outperform -> Outperform	$321.00 -> $300.00	High
1/18/2018	Stephens	Reiterated Rating	Buy	$300.00	High
11/14/2017	Deutsche Bank	Downgrade	Buy -> Hold	$251.00	N/A
11/10/2017	Piper Jaffray	Initiated Coverage	Overweight -> Overweight	$295.00	N/A
11/3/2017	Morgan Stanley	Boost Price Target	Equal Weight	$274.00 -> $290.00	N/A
11/3/2017	Jefferies Group	Boost Price Target	Buy	$270.00 -> $295.00	N/A
11/3/2017	Needham & Company LLC	Boost Price Target	Buy -> Buy	$237.00 -> $285.00	N/A
9/12/2017	Barclays	Reiterated Rating	Overweight	$230.00 -> $253.00	Low
9/6/2017	KeyCorp	Reiterated Rating	Hold		High
6/1/2016	Raymond James	Upgrade	Outperform -> Strong-Buy		N/A
4/28/2016	Brean Capital	Reiterated Rating	Buy	$157.00 -> $168.00	N/A

(Data available from 4/23/2016 forward)

Teleflex (NYSE:TFX) Earnings History and Estimates Chart

Earnings by Quarter for Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) Earnings Estimates

2018 EPS Consensus Estimate: $9.60

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	$1.93	$1.95	$1.94
Q2 2018	4	$2.31	$2.45	$2.40
Q3 2018	4	$2.43	$2.54	$2.48
Q4 2018	4	$2.67	$2.87	$2.78

Teleflex (NYSE TFX) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/3/2018		$2.01					N/A
2/22/2018	Q4 2017	$2.40	$2.44	$601.17 million	$595.10 million	View	Listen
11/2/2017	Q3 2017	$2.01	$2.12	$522.94 million	$534.70 million	View	N/A
8/3/2017	Q2 2017	$1.91	$2.04	$518.98 million	$528.60 million	View	Listen
5/4/2017	Q1 2017	$1.6890	$1.80	$472.81 million	$487.90 million	View	Listen
2/23/2017	Q416	$2.09	$2.13	$502.64 million	$513.90 million	View	Listen
10/27/2016	Q316	$1.78	$1.80	$461.80 million	$455.60 million	View	Listen
7/28/2016	Q216	$1.74	$1.89	$468.40 million	$473.60 million	View	Listen
4/28/2016	Q116	$1.35	$1.52	$425.37 million	$424.90 million	View	Listen
2/25/2016	Q415	$1.92	$2.01	$480.88 million	$484.50 million	View	Listen
10/29/2015	Q315	$1.55	$1.60	$447.61 million	$443.70 million	View	Listen
7/30/2015	Q215	$1.42	$1.42	$453.09 million	$452.00 million	View	Listen
4/30/2015	Q115	$1.27	$1.30	$433.44 million	$429.40 million	View	Listen
2/20/2015	Q414	$1.38	$1.43	$471.42 million	$476.01 million	View	Listen
10/29/2014	Q314	$1.37	$1.57	$447.93 million	$457.20 million	View	Listen
7/30/2014	Q214	$1.34	$1.51	$447.81 million	$468.21 million	View	Listen
4/30/2014	Q114	$1.16	$1.22	$433.20 million	$438.50 million	View	Listen
2/21/2014	Q413	$1.27	$1.36	$437.06 million	$450.50 million	View	Listen
10/30/2013	Q313	$1.14	$1.33	$411.93 million	$413.80 million	View	Listen
7/31/2013	Q2 2013	$1.16	$1.27	$432.18 million	$420.10 million	View	Listen
4/30/2013	Q1 2013	$1.01	$1.03	$416.20 million	$411.90 million	View	Listen
2/21/2013	Q4 2012	$4.90	$4.70	$417.28 million	$419.00 million	View	Listen
10/31/2012		$1.00	$1.04			View	N/A
7/31/2012		$1.10	$1.23			View	N/A
5/1/2012		$0.97	$1.01			View	N/A
2/23/2012		$1.04	$1.07			View	N/A
10/25/2011		$0.81	$1.03			View	N/A
7/27/2011		$0.88	$0.94			View	N/A
4/26/2011		$0.96	$0.96			View	N/A
2/24/2011		$0.92	$1.00			View	N/A
10/26/2010	Q3 2010	$0.97	$1.11			View	N/A
7/22/2010	Q2 2010	$1.03	$1.04			View	N/A
4/27/2010	Q1 2010	$0.89	$0.90			View	N/A
2/24/2010	Q4 2009	$0.99	$1.01			View	N/A
10/27/2009	Q3 2009	$0.89	$0.88			View	N/A
7/27/2009	Q2 2009	$0.88	$0.96			View	N/A
4/28/2009	Q1 2009	$0.66	$0.76			View	N/A
2/25/2009	Q4 2008	$0.94	$1.04			View	N/A
10/28/2008	Q3 2008	$0.97	$1.11			View	N/A
7/29/2008	Q2 2008	$0.92	$1.05			View	N/A
4/29/2008	Q1 2008	$0.81	$0.85			View	N/A
2/28/2008	Q4 2007	$0.97	$0.71			View	N/A

(Earnings results data provided by Zacks Investment Research)

Teleflex (NYSE:TFX) Dividend Information

Teleflex pays an annual dividend of $1.36 per share, with a dividend yield of 0.50%. TFX's most recent quarterly dividend payment was Thursday, March 15. Teleflex pays out 16.19% of its earnings out as a dividend.

Most Recent Dividend:	3/15/2018
Annual Dividend:	$1.36
Dividend Yield:	0.50%
Dividend Growth:	0.00% (3 Year Average)
Payout Ratio:	16.19% (Trailing 12 Months of Earnings) 14.08% (Based on This Year's Estimates) 11.96% (Based on Next Year's Estimates)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/22/2018	quarterly	$0.34	0.53%	3/1/2018	3/2/2018	3/15/2018
11/2/2017	quarterly	$0.34	0.53%	11/14/2017	11/15/2017	12/15/2017
8/3/2017	quarterly	$0.34	0.63%	8/11/2017	8/15/2017	9/15/2017
5/8/2017	quarterly	$0.34	0.7%	5/11/2017	5/15/2017	6/15/2017
2/23/2017	quarterly	$0.34		3/1/2017	3/3/2017	3/15/2017
10/27/2016	quarterly	$0.34	0.98%	11/10/2016	11/15/2016	12/15/2016
7/28/2016	quarterly	$0.34	0.75%	8/11/2016	8/15/2016	9/15/2016
5/2/2016	quarterly	$0.34		5/12/2016	5/16/2016	6/15/2016
2/25/2016	quarterly	$0.34	0.94%	3/2/2016	3/4/2016	3/15/2016
10/29/2015	quarterly	$0.34	1.02%	11/10/2015	11/13/2015	12/14/2015
7/30/2015	quarterly	$0.34	1.02%	8/12/2015	8/14/2015	9/14/2015
5/4/2015	quarterly	$0.34	1.09%	5/12/2015	5/14/2015	6/15/2015
2/20/2015	quarterly	$0.34	1.13%	2/27/2015	3/3/2015	3/16/2015
10/29/2014	quarterly	$0.34		11/12/2014	11/14/2014	12/15/2014
7/30/2014	quarterly	$0.34	1.25%	8/13/2014	8/15/2014	9/15/2014
5/5/2014	quarterly	$0.34	1.31%	5/13/2014	5/15/2014	6/16/2014
2/21/2014	quarterly	$0.34	1.34%	2/28/2014	3/4/2014	3/14/2014
10/30/2013	quarterly	$0.34	1.49%	11/13/2013	11/15/2013	12/13/2013
7/31/2013	quarterly	$0.34	1.72%	8/13/2013	8/15/2013	9/13/2013
5/3/2013	quarterly	$0.34	1.75%	5/13/2013	5/15/2013	6/14/2013
2/21/2013	quarterly	$0.34	1.74%	3/1/2013	3/5/2013	3/15/2013

(Data available from 1/1/2013 forward)

Teleflex (NYSE TFX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.56%
Institutional Ownership Percentage: 90.49%

Insider Trading History for Teleflex (NYSE:TFX)

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Teleflex (NYSE TFX) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2018	Benson Smith	Director	Sell	9,331	$260.52	$2,430,912.12	77,498
4/9/2018	George Babich Jr	Director	Sell	2,500	$246.87	$617,175.00	11,083
4/2/2018	Benson Smith	Director	Sell	9,331	$251.49	$2,346,653.19	83,711
3/26/2018	George Babich Jr	Director	Sell	2,500	$254.53	$636,325.00	8,794
3/12/2018	George Babich Jr	Director	Sell	2,500	$268.53	$671,325.00	11,083
2/28/2018	John Deren	VP	Sell	1,359	$255.67	$347,455.53
2/26/2018	George Babich Jr	Director	Sell	2,500	$255.61	$639,025.00	8,886
2/12/2018	George Babich Jr	Director	Sell	2,500	$252.57	$631,425.00	10,259
2/1/2018	Stephen K M.D. Klasko	Director	Sell	200	$276.44	$55,288.00	8,080
1/29/2018	George Babich Jr	Director	Sell	2,500	$283.11	$707,775.00	9,581
1/16/2018	George Babich Jr	Director	Sell	2,500	$263.38	$658,450.00	10,583
1/2/2018	Stephen K M.D. Klasko	Director	Sell	200	$248.96	$49,792.00	8,080
12/4/2017	Benson Smith	CEO	Sell	2,000	$258.10	$516,200.00	76,634
12/1/2017	Stephen K M.D. Klasko	Director	Sell	200	$265.32	$53,064.00	8,080
11/1/2017	Stephen K M.D. Klasko	Director	Sell	200	$237.18	$47,436.00	8,080
10/2/2017	Stephen K M.D. Klasko	Director	Sell	200	$241.88	$48,376.00	8,080
9/1/2017	Stephen K M.D. Klasko	Director	Sell	200	$211.75	$42,350.00	8,080
8/1/2017	Stephen K M.D. Klasko	Director	Sell	200	$208.41	$41,682.00	8,080
7/3/2017	Stephen K M.D. Klasko	Director	Sell	200	$208.10	$41,620.00	8,080
6/21/2017	Gretchen R Haggerty	Director	Buy	1,000	$203.82	$203,820.00	1,760
6/7/2017	Stuart A Randle	Director	Sell	2,500	$205.67	$514,175.00	7,532
6/1/2017	Stephen K M.D. Klasko	Director	Sell	200	$199.93	$39,986.00	8,080
5/15/2017	Stephen K M.D. Klasko	Director	Sell	5,200	$193.56	$1,006,512.00	12,880
5/9/2017	John Deren	VP	Sell	2,246	$194.07	$435,881.22	3,989
12/21/2016	Jeffrey A Graves	Director	Sell	5,000	$160.57	$802,850.00	13,022
6/6/2016	Stuart A Randle	Director	Sell	797	$166.10	$132,381.70	4,592
5/16/2016	Thomas Anthony Kennedy	VP	Sell	15,102	$160.20	$2,419,340.40	6,990
8/20/2015	Patricia C Barron	Director	Sell	1,500	$132.74	$199,110.00	7,623
12/22/2014	Liam Kelly	EVP	Sell	3,360	$117.38	$394,396.80
12/1/2014	George Babich Jr	Director	Sell	5,000	$118.20	$591,000.00
9/5/2013	William Roland Cook	Director	Sell	2,696	$77.32	$208,454.72
8/8/2013	Patricia Barron	Director	Sell	4,000	$77.66	$310,640.00	5,677

(Data available from 1/1/2013 forward)

Teleflex (NYSE TFX) News Headlines

Source:

Date	Headline
	Teleflex (TFX) vs. Its Rivals Head-To-Head Survey www.americanbankingnews.com - April 22 at 11:18 AM
	Teleflex (TFX) versus Antares Pharma (ATRS) Critical Analysis www.americanbankingnews.com - April 21 at 7:20 PM
	Critical Contrast: Teleflex (TFX) versus Its Rivals www.americanbankingnews.com - April 21 at 3:06 PM
	Teleflex Announces First Quarter 2018 Earnings Conference Call Information finance.yahoo.com - April 19 at 9:29 AM
	Can Business Services Aid athenahealth's (ATHN) Q1 Earnings? finance.yahoo.com - April 19 at 9:29 AM
	Benson Smith Sells 9,331 Shares of Teleflex Incorporated (TFX) Stock www.americanbankingnews.com - April 17 at 7:11 PM
	Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres finance.yahoo.com - April 17 at 4:50 PM
	Teleflex (TFX) Downgraded by BidaskClub www.americanbankingnews.com - April 14 at 8:37 PM
	Teleflex's (TFX) Buy Rating Reaffirmed at Jefferies Group www.americanbankingnews.com - April 13 at 11:43 PM
	Teleflex Incorporated (TFX) Expected to Announce Quarterly Sales of $568.54 Million www.americanbankingnews.com - April 13 at 4:31 AM
	Edited Transcript of TFX presentation 7-Mar-17 8:25pm GMT finance.yahoo.com - April 12 at 10:23 AM
	Estimating The Intrinsic Value Of Teleflex Incorporated (NYSE:TFX) finance.yahoo.com - April 12 at 10:23 AM
	Teleflex (TFX) Given "Buy" Rating at Jefferies Group www.americanbankingnews.com - April 11 at 7:19 PM
	Brokerages Expect Teleflex Incorporated (TFX) Will Post Earnings of $1.94 Per Share www.americanbankingnews.com - April 11 at 8:23 AM
	Teleflex Incorporated (TFX) Receives Consensus Recommendation of "Hold" from Brokerages www.americanbankingnews.com - April 11 at 5:31 AM
	Insider Selling: Teleflex Incorporated (TFX) Director Sells 2,500 Shares of Stock www.americanbankingnews.com - April 10 at 7:11 PM
	Teleflex (TFX) Stock Rating Reaffirmed by KeyCorp www.americanbankingnews.com - April 9 at 12:10 PM
	Teleflex (TFX) versus Its Peers Critical Comparison www.americanbankingnews.com - April 9 at 3:13 AM
	Teleflex (TFX) Rating Reiterated by Barclays www.americanbankingnews.com - April 8 at 10:46 PM
	Teleflex (TFX) & The Competition Critical Contrast www.americanbankingnews.com - April 7 at 1:27 PM
	Teleflex Incorporated (TFX) Director Benson Smith Sells 9,331 Shares www.americanbankingnews.com - April 4 at 10:20 PM
	Teleflex (TFX) Now Covered by Goldman Sachs www.americanbankingnews.com - April 4 at 8:04 AM
	Teleflex (TFX) & Its Peers Critical Review www.americanbankingnews.com - April 1 at 5:38 AM
	Teleflex Incorporated (TFX) Director George Babich, Jr. Sells 2,500 Shares www.americanbankingnews.com - March 27 at 10:14 PM
	Teleflex (TFX) Stock Rating Reaffirmed by Stephens www.americanbankingnews.com - March 27 at 1:17 PM
	Fluidigm (FLDM) vs. Teleflex (TFX) Head-To-Head Contrast www.americanbankingnews.com - March 27 at 9:22 AM
	$568.54 Million in Sales Expected for Teleflex Incorporated (TFX) This Quarter www.americanbankingnews.com - March 27 at 7:34 AM
	Teleflex's (TFX) "Buy" Rating Reiterated at Leerink Swann www.americanbankingnews.com - March 26 at 3:13 PM
	Teleflex Incorporated (TFX) Expected to Post Earnings of $1.94 Per Share www.americanbankingnews.com - March 25 at 8:49 AM
	Edited Transcript of TFX earnings conference call or presentation 22-Feb-18 1:00pm GMT finance.yahoo.com - March 20 at 4:18 PM
	Q1 2018 Earnings Estimate for Teleflex Incorporated Issued By William Blair (TFX) www.americanbankingnews.com - March 20 at 7:46 AM
	Analysts’ Recommendations for Haemonetics and Peers in March 2018 finance.yahoo.com - March 19 at 4:20 PM
	Teleflex Incorporated (TFX) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - March 17 at 5:35 AM
	Teleflex (TFX) Lowered to C+ at TheStreet www.americanbankingnews.com - March 14 at 2:36 PM
	Teleflex to Present at Needham & Company’s 17th Annual Healthcare Conference finance.yahoo.com - March 13 at 9:49 AM
	Teleflex (TFX) Cut to Hold at ValuEngine www.americanbankingnews.com - March 11 at 8:18 PM
	Teleflex Incorporated (TFX) Expected to Announce Quarterly Sales of $568.96 Million www.americanbankingnews.com - March 10 at 10:29 AM
	Teleflex (TFX) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow seekingalpha.com - March 8 at 5:18 PM
	Here's Why Teleflex Has Been Losing Ground Since Q4 Earnings finance.yahoo.com - March 6 at 4:47 PM
	Lombard Odier Asset Management Switzerland SA Boosts Position in Teleflex Incorporated (TFX) www.americanbankingnews.com - March 6 at 1:09 PM
	Here's Why Teleflex Has Been Losing Ground Since Q4 Earnings www.zacks.com - March 6 at 9:20 AM
	Teleflex to Present at the 28th Annual Oppenheimer Healthcare Conference finance.yahoo.com - March 6 at 9:20 AM
	Teleflex Incorporated (TFX) Shares Bought by Amalgamated Bank www.americanbankingnews.com - March 5 at 4:22 AM
	Allianz Asset Management GmbH Has $38.16 Million Position in Teleflex Incorporated (TFX) www.americanbankingnews.com - March 4 at 4:16 AM
	Teleflex Incorporated (TFX) Holdings Reduced by Citadel Advisors LLC www.americanbankingnews.com - March 3 at 5:21 AM
	Teleflex Incorporated (TFX) Stake Increased by UBS Asset Management Americas Inc. www.americanbankingnews.com - March 2 at 7:50 PM
	Teleflex Incorporated (TFX) Position Cut by Credit Agricole S A www.americanbankingnews.com - March 2 at 3:47 PM
	Carillon Tower Advisers Inc. Invests $3.01 Million in Teleflex Incorporated (TFX) www.americanbankingnews.com - March 2 at 5:34 AM
	Ascend Capital LLC Takes $4.39 Million Position in Teleflex Incorporated (TFX) www.americanbankingnews.com - March 2 at 4:33 AM
	Insider Selling: Teleflex Incorporated (TFX) VP Sells 1,359 Shares of Stock www.americanbankingnews.com - March 1 at 9:46 PM

Teleflex (NYSE:TFX) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Teleflex (NYSE:TFX) Income Statement, Balance Sheet and Cash Flow Statement

Teleflex (NYSE TFX) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff